Bolt Biotherapeutics's market cap is currently $10.40M. The company's EPS TTM is $-4.46; its P/E ratio is ―; Bolt Biotherapeutics is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-6.18. See an overview of income statement, balance sheet, and cash flow financials.
